Omniscope is pleased to welcome Dr. Simo Arredouani, PhD, as our new Vice President of Immunology and Strategic Partnerships. Dr. Arredouani is a distinguished leader in immuno-oncology, bringing over 20 years of experience in developing innovative cell, antibody, and vaccine therapies for cancer. His extensive expertise in pre-clinical and translational research across academic and biotech settings, combined with his visionary leadership, will be pivotal in propelling our work and advancing patient care.

Dr. Arredouani on joining Omniscope:

“The opportunity to apply Omniscope's innovative platform to accelerate discoveries in immunology and immunotherapy perfectly aligns with my passion for developing novel therapies that can change patients’ lives. I am looking forward to collaborating with the brilliant team at Omniscope and driving impactful science.”

Omniscope CEO, Vijay Vaswani, on welcoming Dr. Arredouani:

“Dr. Arredouani’s deep expertise and innovative approach make him an exceptional fit for Omniscope. His leadership will be instrumental as we leverage cutting‐edge immune data to drive breakthroughs in patient care, and I am excited to see the transformative impact his vision brings to our mission.”

We are thrilled to welcome Dr. Arredouani to the Omniscope team. His expertise and vision will be instrumental as we continue to advance our mission and transform healthcare through the power of immune data.

‍

_{ABOUT OMNISCOPE
Omniscope is building the world’s largest Immune Databank to bring healthcare to everyone, everywhere, by unlocking the full potential of immune data. Through proprietary laboratory and AI technology, Omniscope generates high-resolution immune insights at an unprecedented scale, empowering scientists and healthcare providers to uncover complex patterns and predict immune responses with precision. Our mission is to drive breakthroughs in personalized medicine and set a new standard in immune health.}